Advanz Pharma
Also known as: ADVANZ PHARMA | at the request of Concordia Laboratories Inc. | CONCORDIA | Concordia Healthcare | Concordia Laboratories Inc. | CONCORDIA LABS INC | Concordia Pharmaceuticals | Concordia Pharmaceuticals, Inc | Concordia Pharmaceuticals Inc., Barbados | CONCORDIA PHARMS INC
Highest phase reached
Phase 4
Timeline
1950s
- Apr 18, 1955
hydroxychloroquine— Marketing Organization
- Apr 18, 1955
hydroxychloroquine— NDA Organization
2010s
- Jan 20, 2010
Advanz Pharma— Founded
- Jan 1, 2013
Pinnacle Biologics— Acquired
- Oct 1, 2013
Complete Medical Homecare— Acquired
- Dec 18, 2013
Mercari Acquisition Corp.— Acquired
- Jan 1, 2015
Covis— Acquired
- Sep 7, 2015
AMCo— Acquired
- Oct 21, 2015
Amdipharm— Acquired - Mar 29, 2019
aclidinium— NDA Secondary Org
2020s
- Mar 16, 2020
Correvio— Acquired
Drugs by trial phase (47 distinct, 86 trials)
Phase 4 (1 own, 8 via acquisition)
Phase 3 (2 own, 13 via acquisition)
Phase 2 (1 own, 15 via acquisition)
Phase 1 (1 own, 5 via acquisition)
Other trials (0 own, 1 via acquisition)
Indications
Approved for
Marketed drugs (18)
Subsidiaries (7 direct, 14 total across the full acquisition tree)
Recent trials (9)
- NCT05117398CollaboratorPhase 3Jan 3, 2022
- NCT03344861Lead sponsorPhase 1Aug 14, 2017
- NCT03344861Study chairPhase 1Aug 14, 2017
- NCT02916745Lead sponsorPhase 4Jan 26, 2017
- NCT02916745Study directorPhase 4Jan 26, 2017
- NCT02082522Lead sponsorPhase 3Aug 1, 2014
- NCT01439126Lead sponsorPhase 4Aug 1, 2011
- NCT00531401Lead sponsorPhase 2Sep 1, 2007
- NCT00867230CollaboratorPhase 1May 1, 2006
Details
- Founded
- Mississauga, CA Jan 20, 2010
- Last known activity
- Oct 16, 2025
Designations held
- Orphan drug
- Priority review